The Use of an Erectogenic Pharmacotherapy Regimen Following Radical Prostatectomy Improves Recovery of Spontaneous Erectile Function
- 1 July 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 2 (4) , 532-540
- https://doi.org/10.1111/j.1743-6109.2005.00081_1.x
Abstract
Purpose: It has been suggested that postradical prostatectomy (RP) erectile function outcomes are improved by early use of erectogenic medications. This analysis was designed to assess the ability of a post-RP vasoactive drug program to improve long-term spontaneous erectile function. Methods: Men with functional preoperative erections who underwent RP were challenged early postoperatively with oral sildenafil. Nonresponders were switched to intracavernosal injection therapy (ICI). Patients were instructed to inject three times a week. Only patients who presented within 6 months post RP, who completed the International Index of Erectile Function (IIEF) questionnaire on at least three separate occasions after surgery, and who had been followed for at least 18 months were included. Data from men who were committed to rehabilitation were compared with those of men who did not follow the protocol but continued to be followed serially following RP. Results: There were 58 patients in the rehabilitation (R) group and 74 in the nonrehabilitation (NR) group. No differences existed in mean patient age, comorbidity profile, intraoperative nerve sparing status, or postoperative erectile hemodynamics between the two groups. At 18 months post RP, there were statistically significant differences between the two groups in the percentage of patients who were capable of having medication-unassisted intercourse (R = 52% vs. NR = 19%, P < 0.001); mean erectile rigidity (R = 53 ± 21% vs. NR = 26 ± 43%, P < 0.01); mean IIEF erectile function (EF) domain scores (R = 22 ± 6 vs. NR = 12 ± 14, P < 0.01); the percentage of patients with normal EF domain scores (R = 22% vs. NR = 6%, P < 0.01); the percentage of patients responding to sildenafil (R = 64% vs. NR = 24%, P < 0.001); the time to become a sildenafil responder (R = 9 ± 4 vs. NR = 13 ± 3 months, P = 0.02); and the percentage of patients responding to ICI (R = 95% vs. NR = 76%, P < 0.01). Conclusions: The data generated from this nonrandomized study indicate that a pharmacologic penile rehabilitation protocol results in higher rates of spontaneous functional erections and erectogenic drug response after RP.Keywords
This publication has 25 references indexed in Scilit:
- Neuroprotective strategies in radical prostatectomyBJU International, 2004
- Predictors of Treatment After Initial Surveillance in Men With Prostate Cancer: Results From CaPSUREJournal of Urology, 2003
- ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY: HEMODYNAMIC PROFILES AND THEIR CORRELATION WITH THE RECOVERY OF ERECTILE FUNCTIONJournal of Urology, 2002
- FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMYJournal of Urology, 2000
- ASSESSMENT OF THE FUNCTIONAL ROLE OF ACCESSORY PUDENDAL ARTERIES IN ERECTION BY TRANSRECTAL COLOR DOPPLER ULTRASOUNDJournal of Urology, 1999
- Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of ImpotenceInternational Journal Of Impotence Research, 1998
- The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunctionUrology, 1997
- Return of Erections and Urinary Continence Following Nerve Sparing Radical Retropubic ProstatectomyJournal of Urology, 1993
- Duplex Doppler ultrasonography: Noninvasive assessment of penile anatomy and functionSeminars in Roentgenology, 1993
- Sexual Function following Radical Prostatectomy: Influence of Preservation of Neurovascular BundlesJournal of Urology, 1991